829 related articles for article (PubMed ID: 10477778)
1. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
2. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
[TBL] [Abstract][Full Text] [Related]
3. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
[TBL] [Abstract][Full Text] [Related]
4. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
5. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).
Simioni P; Prandoni P; Lensing AW; Scudeller A; Sardella C; Prins MH; Villalta S; Dazzi F; Girolami A
N Engl J Med; 1997 Feb; 336(6):399-403. PubMed ID: 9010145
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
DeSancho MT; Berlus N; Christos PJ; Rand J
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
[TBL] [Abstract][Full Text] [Related]
7. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism.
Margaglione M; D'Andrea G; Colaizzo D; Cappucci G; del Popolo A; Brancaccio V; Ciampa A; Grandone E; Di Minno G
Thromb Haemost; 1999 Dec; 82(6):1583-7. PubMed ID: 10613638
[TBL] [Abstract][Full Text] [Related]
9. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation.
Lindmarker P; Schulman S; Sten-Linder M; Wiman B; Egberg N; Johnsson H
Thromb Haemost; 1999 May; 81(5):684-9. PubMed ID: 10365737
[TBL] [Abstract][Full Text] [Related]
10. Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis.
van Dunné FM; Doggen CJ; Heemskerk M; Rosendaal FR; Helmerhorst FM
Hum Reprod; 2005 Mar; 20(3):802-6. PubMed ID: 15618258
[TBL] [Abstract][Full Text] [Related]
11. [Pregnancy-associated venous thrombosis in women with hereditary heterozygous factor V Leiden and/or factor II gene mutations].
Samama MM; Rached RA; Conard J; Horellou MH; Elalamy I
Bull Acad Natl Med; 2004; 188(8):1377-93; discussion 1393-6. PubMed ID: 15918665
[TBL] [Abstract][Full Text] [Related]
12. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.
Ridker PM; Hennekens CH; Lindpaintner K; Stampfer MJ; Eisenberg PR; Miletich JP
N Engl J Med; 1995 Apr; 332(14):912-7. PubMed ID: 7877648
[TBL] [Abstract][Full Text] [Related]
13. Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.
Lenicek Krleza J; Jakovljevic G; Bronic A; Coen Herak D; Bonevski A; Stepan-Giljevic J; Roic G
Pathophysiol Haemost Thromb; 2010; 37(1):24-9. PubMed ID: 20664190
[TBL] [Abstract][Full Text] [Related]
14. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
Rahimi Z; Mozafari H; Bigvand AH; Doulabi RM; Vaisi-Raygani A; Afshari D; Razazian N; Rezaei M
Clin Appl Thromb Hemost; 2010 Aug; 16(4):430-4. PubMed ID: 19703820
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vessels.
Arsov T; Miladinova D; Spiroski M
Croat Med J; 2006 Jun; 47(3):433-9. PubMed ID: 16758522
[TBL] [Abstract][Full Text] [Related]
16. Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.
Cordoba I; Pegenaute C; González-López TJ; Chillon C; Sarasquete ME; Martin-Herrero F; Guerrero C; Cabrero M; Garcia Sanchez MH; Pabon P; Lozano FS; Gonzalez M; Alberca I; González-Porras JR
Eur J Haematol; 2012 Sep; 89(3):250-5. PubMed ID: 22642978
[TBL] [Abstract][Full Text] [Related]
17. High levels of coagulation factor XI as a risk factor for venous thrombosis.
Meijers JC; Tekelenburg WL; Bouma BN; Bertina RM; Rosendaal FR
N Engl J Med; 2000 Mar; 342(10):696-701. PubMed ID: 10706899
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry.
Gadelha T; Roldán V; Lecumberri R; Trujillo-Santos J; del Campo R; Poggio R; Monreal M;
Thromb Res; 2010 Oct; 126(4):283-6. PubMed ID: 20627204
[TBL] [Abstract][Full Text] [Related]
19. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.
Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846
[TBL] [Abstract][Full Text] [Related]
20. Factor V Leiden and prothrombin gene G20210A mutation and in vitro fertilization: prospective cohort study.
Ricci G; Bogatti P; Fischer-Tamaro L; Giolo E; Luppi S; Montico M; Ronfani L; Morgutti M
Hum Reprod; 2011 Nov; 26(11):3068-77. PubMed ID: 21868400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
